Day: March 31, 2026

Chagee Announces Fourth Quarter and Full Year 2025 Unaudited Financial Results

Written by Customer Service on March 31, 2026. Posted in Public Companies.

SHANGHAI, March 31, 2026 (GLOBE NEWSWIRE) — Chagee Holdings Limited (NASDAQ: CHA) (“Chagee” or the “Company”), a leading premium tea drinks brand serving healthy and delicious freshly-made tea drinks, today announced its unaudited financial results for the fourth quarter and full year ended December 31, 2025. Fourth Quarter and Full Year 2025 Operational Highlights1As of December 31, 2025, there were 7,453 teahouses within the Company’s teahouse network in Greater China and overseas, representing a 15.7% increase in the number of teahouses as of December 31, 2024. Total GMV generated in the fourth quarter of 2025 was RMB7,322.9 million. Geographically, total GMV generated in overseas markets was RMB371.9 million in the fourth quarter of 2025, representing an 84.6% year-over-year increase; total GMV generated in Greater China market...

Bitfarms Reports Fiscal Year 2025 Results

Written by Customer Service on March 31, 2026. Posted in Public Companies.

Commercialization efforts underway at Panther Creek (PA), Sharon (PA), and Moses Lake (WA) $520 million of cash and Bitcoin on the balance sheet to support site development as of March 27, 2026 Continuing to advance 2.2 GW development pipeline across Washington state, Pennsylvania and Québec sites Shareholders approved redomiciliation to the U.S. from Canada; closing of the transaction expected on or about April 1, 2026; Bitfarms will rebrand to Keel Infrastructure on closing TORONTO, Ontario and NEW YORK, March 31, 2026 (GLOBE NEWSWIRE) — Bitfarms Ltd. (Nasdaq/TSX: BITF) (“Bitfarms” or the “Company”), a North American digital and energy infrastructure company, today reported its financial results for the year ended December 31, 2025. All financial references are in U.S. dollars. The Company has transitioned...

YXT.com Reports Full Year 2025 Unaudited Financial Results

Written by Customer Service on March 31, 2026. Posted in Public Companies.

SUZHOU, China, March 31, 2026 (GLOBE NEWSWIRE) — YXT.com Group Holding Limited (NASDAQ: YXT) (“YXT.com” or the “Company”), a provider of AI-enabled enterprise productivity solutions, today announced its unaudited financial results for the full year ended December 31, 2025. Financial Highlights for the Full Year of 2025Total revenues were RMB340.2 million (US$48.7 million) for the full year of 2025, compared with RMB331.2 million in the prior year, representing an increase of 2.7%. Gross margin was 68.3% for the full year of 2025, compared with 61.8% in the prior year, representing an increase of 6.5 percentage points. Net loss was RMB158.9 million (US$22.7 million), compared with RMB92.1 million in the prior year. Adjusted net loss was RMB146.6 million (US$21.0 million), compared with RMB199.3 million in the prior year, representing...

Biogen to Acquire Apellis, Enhancing the Company’s Growth Portfolio in Immunology and Rare Disease, Bolstering Growth Outlook and Accelerating Expansion into Nephrology

Written by Customer Service on March 31, 2026. Posted in Mergers And Acquisitions.

Acquisition will bring two differentiated commercialized immunology medicines to Biogen with EMPAVELI® FDA-approved in three indications, including two rare kidney diseases, and SYFOVRE® FDA-approved in geographic atrophy, an immune-mediated retinal disease Bringing together Biogen and Apellis’ commercialization capabilities will maximize the potential of both EMPAVELI® and SYFOVRE®, while Apellis’ talent and expertise will accelerate Biogen’s entry into nephrology and augment launch readiness for felzartamab, currently in Phase 3 Acquisition is expected to bolster Biogen’s near-and long-term growth prospects, adding immediate revenue from two products with significant growth potential; 2025 net product revenue for EMPAVELI® and SYFOVRE® together was $689 million, expected to grow at a rate in the mid-to-high teens at least through 2028 Biogen...

SCYNEXIS Announces $40.0 Million Private Placement

Written by Customer Service on March 31, 2026. Posted in Public Companies.

JERSEY CITY, N.J., March 31, 2026 (GLOBE NEWSWIRE) — SCYNEXIS, Inc. (NASDAQ: SCYX) (“SCYNEXIS” or the “Company”), a biotechnology company focused on developing innovative new therapies to address severe rare diseases including SCY-770 for Autosomal Dominant Polycystic Kidney Disease (ADPKD), today announced that it has entered into a securities purchase agreement with certain new and existing institutional and accredited investors. The Company anticipates upfront gross proceeds from the private placement to be approximately $40.0 million, before deducting placement agent fees and transaction-related expenses, and up to an additional $52.2 million in gross proceeds if the Common Warrants are fully exercised for cash, subject to Stockholder Approval of shares of common stock issuable upon exercise of the Common Warrants. The private...

SCYNEXIS Completes Transformative Acquisition of PXL-770, an innovative, highly selective, direct AMPK activator for the Treatment of Autosomal Dominant Polycystic Kidney Disease (ADPKD)

Written by Customer Service on March 31, 2026. Posted in Mergers And Acquisitions.

PXL-770 (now SCY-770) is a clinical stage, well-characterized oral therapy designed to address the underlying drivers of ADPKD by reducing cyst growth and disease progression A Phase 2 proof-of-concept study of SCY-770 in ADPKD patients is anticipated to begin in Q4 2026 with an early efficacy readout anticipated in the second half of 2027 With this acquisition, SCYNEXIS strengthens its mission to develop innovative solutions for severe and rare diseases, unlocking further opportunities for value creationSCYNEXIS will host a conference call on March 31, 2026 at 8:30 a.m. ET to provide a corporate update. JERSEY CITY, N.J., March 31, 2026 (GLOBE NEWSWIRE) — SCYNEXIS, Inc. (NASDAQ: SCYX), a biotechnology company focused on developing innovative new therapies to address severe rare diseases, today announced that it has entered...

BOSS Zhipin Continues Share Repurchases, with Total Repurchases Amounting to Over RMB576 Million in 2026

Written by Customer Service on March 31, 2026. Posted in Public Companies.

BEIJING, March 31, 2026 (GLOBE NEWSWIRE) — KANZHUN LIMITED (“BOSS Zhipin” or the “Company”) (Nasdaq: BZ; HK: 2076) today announced the continued execution of its share repurchase program, utilizing around RMB34.5 million to repurchase 744,334 ordinary shares on March 30. Year-to-date in 2026, the Company has deployed over RMB576 million toward share repurchases. This move underscores the Company’s ongoing commitment to shareholder returns. CONTACT: CONTACT: PIACENTE FINANCIAL COMMUNICATIONS kanzhun@tpg-ir.com

QIND Reports FY 2025 Results: 45.9% Revenue Growth, Core Turnaround Actions Completed

Written by Customer Service on March 31, 2026. Posted in Public Companies.

SAN FRANCISCO, CA, March 31, 2026 (GLOBE NEWSWIRE) — Quality Industrial Corp. (“QIND”) (OTC: QIND), today announced its financial results for fiscal year 2025 alongside this letter to shareholders summarizing the turnaround actions completed during the year. Dear Shareholders, Fiscal year 2025 was a pivotal turnaround year for QIND. Over the past fifteen months, your Board and management team have strengthened governance, restructured costs, cleaned up the balance sheet, and invested in growth. While the turnaround is not yet complete, we believe the progress has been substantial. This letter provides an overview of what was achieved and what lies ahead. Financial Highlights FY 2025 FY 2024 Change Revenue $ 16,307,787 $ 11,177,567 +45.9 %Gross Profit $ 4,788,780 $ 3,963,263 +20.8 %Gross...

SATO continues its profitable growth: The company acquires 602 rental homes from OP Vuokrakoti Ky

Written by Customer Service on March 31, 2026. Posted in Public Companies.

SATO Corporation, Press release 31 March 2026 at 1:15 pm The housing investor SATO and OP Vuokrakoti Ky have today signed a purchase agreement covering OP Vuokrakoti Ky’s entire housing portfolio. Ownership of eight apartment buildings and a total of 602 rental homes have been transferred to SATO. The parties have agreed not to disclose the purchase price. With today’s transaction, the homes and their valid rental agreements have been transferred to SATO. “Our acquired housing portfolio is of exceptionally high quality: The properties are new, energy-efficient and in excellent condition. The portfolio’s economic occupancy rate exceeded 97% last year. We are very pleased with the completion of the transaction,” says Antti Aarnio, CEO of SATO Oyj. The housing transaction supports SATO’s strategy for profitable growth and further strengthens...

Aalberts reports the progress of its share buyback programme 23 – 27 March 2026

Written by Customer Service on March 31, 2026. Posted in Public Companies.

Utrecht, 31 March 2026 Aalberts today reports that it has repurchased 214,849 of its own shares in the period from 23 March 2026, up and including 27 March 2026, for an amount of EUR 6,446,494.52, so at an average share price of EUR 30.00. This is part of the share buyback programme as announced on 26 February 2026, for a total amount of EUR 75 million. The repurchase of shares commenced on 27 February 2026 and will be completed no later than 9 October 2026. It is intended that the shares will be cancelled following repurchase. Up to and including 27 March 2026, a cumulative total of 883,622 shares was repurchased under the share buyback programme for a total consideration of EUR 27,976,238. Aalberts has engaged an intermediary to repurchase the Aalberts shares in the open market, during open and closed periods, independent of Aalberts. The...

Day: March 31, 2026

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals